hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 11:15:07 - browse：2

WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Beyond aggravation: Constipation is an American epidemic

WSS

Alkermes shareholders re

Anesthesiologist group: stop taking Ozempic before surgery

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

The world needs the new pandemic treaty

Activists slam private health insurers over coverage restrictions

knowledge

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

ChatGPT in medicine: STAT answers readers' burning questions

Cancer drug shortages should be causing more outrage

Clinicians often fail to acknowledge the pain caused by long Covid

As demand for Covid shots wanes, Moderna seeks its next success

After affirmative action ruling, medical educators look to 'holistic review'

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Hollywood unions extend contract negotiations for actors

The cancer drug shortage isn’t new — and neither are the solutions

Guardant Health colon cancer test endorsed by FDA advisory panel

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Hepatitis C has a cure — but many Americans still lack access to it

Alkermes shareholders re

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Decentralized clinical trials need collaboration to achieve wider use

The high cost of giving birth even with insurance

knowledge

entertainment

Wikipedia

knowledge